Current methods for the isolation of extracellular vesicles

Biological Chemistry

Volumn 394, Issue 10, 2013, Pages 1253-1262

  Momen Heravi, Fatemeh ^a   Balaj, Leonora ^c   Alian, Sara ^a   Mantel, Pierre Yves ^d   Halleck, Allison E ^a   Trachtenberg, Alexander J ^a   Soria, Cesar E ^e   Oquin, Shanice ^f   Bonebreak, Christina M ^b   Saracoglu, Elif ^g   Skog, Johan ^h   Kuo, Winston Patrick ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f UNIVERSITY OF NORTH TEXAS   (United States)

^g ISTANBUL UNIVERSITY   (Turkey)

^h Exosome Diagnostics Inc   (United States)

Author keywords

Clinical grade EVs; Exosomes; Magnetic beads; Microvesicles; Sedimentation efficiency; Ultracentrifugation

Indexed keywords

ACETYLCHOLINESTERASE; BETA ACTIN; ENOLASE; GLYCERALDEHYDE 3 PHOSPHATE; HEAT SHOCK COGNATE PROTEIN 70; IODIXANOL; LIPOCORTIN 2; LIPOCORTIN 5; LIPOPROTEIN LIPASE; MICRORNA; PHOSPHATE BUFFERED SALINE; TETRASPANIN; TUMOR ANTIGEN;

ACCELERATION; ACCURACY; BIOTECHNOLOGY; BODY FLUID; CARCINOMA CELL; CELL CULTURE; CELL ISOLATION; CELL VACUOLE; CENTRIFUGATION; CHROMATOGRAPHY; CULTURE MEDIUM; DENDRITIC CELL; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; EXTRACELLULAR VESICLE; FLOTATION; GOOD MANUFACTURING PRACTICE; HUMAN IMMUNODEFICIENCY VIRUS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROFILTRATION; MICROFLUIDICS; MONOCYTE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEDIMENTATION; SUCROSE GRADIENT; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; VIRION; VISCOSITY;

BIOLOGY; CELL BIOLOGY; CENTRIFUGATION, DENSITY GRADIENT; EXOSOMES; MICROFLUIDICS; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 84888103828     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0141     Document Type: Review

References (69)

1. Alaniz, R.C., Deatherage, B.L., Lara, J.C., and Cookson, B.T. (2007). Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179, 7692-7701.
2. Antwi-Baffour, S., Kholia, S., Aryee, Y.K., Ansa-Addo, E.A., Stratton, D., Lange, S., and Inal, J.M. (2010). Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells - possible role in SLE. Biochem. Biophys. Res. Commun. 398, 278-283.
3. Aoki, M., Kondo, M., Nakatsuka, Y., Kawai, K., and Oshima, S. (2007). Stationary phase culture supernatant containing membrane vesicles induced immunity to rainbow trout Oncorhynchus mykiss fry syndrome. Vaccine 25, 561-569. (Pubitemid 44856087)
4. Ashcroft, B.A., de Sonneville, J., Yuana, Y., Osanto, S., Bertina, R., Kuil, M.E., and Oosterkamp, T.H. (2012). Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics. Biomed. Microdevices 14, 641-649.
5. Azevedo, L.C., Pedro, M.A., and Laurindo, F.R. (2007). Circulating microparticles as therapeutic targets in cardiovascular diseases. Recent Pat. Cardiovasc. Drug Discov. 2, 41-51. (Pubitemid 46813415)
6. Baj-Krzyworzeka, M., Szatanek, R., Weglarczyk, K., Baran, J., and Zembala, M. (2007). Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol. Lett. 113, 76-82. (Pubitemid 47562121)
7. Balaj, L., Lessard, R., Dai, L., Cho, Y.J., Pomeroy, S.L., Breakefield, X.O., and Skog, J. (2011). Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2, 180.
8. Bishop, A.L., Tarique, A.A., Patimalla, B., Calderwood, S.B., Qadri, F., and Camilli, A. (2012). Immunization of mice with Vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission. J. Infect. Dis. 205, 412-421.
9. Bjune, G., Høiby, E.A., Grønnesby, J.K., Arnesen, O., Fredriksen, J.H., Halstensen, A., Holten, E., Lindbak, A.K., Nøkleby, H., and Rosenqvist, E. (1991). Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338, 1093-1096.
10. Bu, N., Wu, H., Sun, B., Zhang, G., Zhan, S., Zhang, R., and Zhou, L. (2011). Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma. J. Neurooncol. 104, 659-667.
11. Camacho, A.I., de Souza, J., Sánchez-Gómez, S., Pardo-Ros, M., Irache, J.M., and Gamazo, C. (2011). Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. Vaccine 29, 8222-8229.
12. Cantin, R., Diou, J., Bélanger, D., Tremblay, A.M., and Gilbert, C. (2008). Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J. Immunol. Methods 338, 21-30.
13. Chen, C., Skog, J., Hsu, C., Lessard, R.T., Balaj, L., Wurdinger, T., Carter, B.S., Breakefield, X.O., Toner, M., and Irimia, D. (2010). Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab. Chip. 10, 505-511.
14. Cheruvanky, A., Zhou. H., Pisitkun, T., Kopp. J.B., Knepper M.A., Yuen P.S., and Star, R.A. (2007). Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am. J. Physiol. Renal Physiol. 292, 1657-1661.
15. Clayton, A., Court, J., Navabi, H., Adams, M., Mason, M.D., Hobot, J.A., Newman, G.R., and Jasani, B. (2001). Analysis of antigen presenting cell derived exosomes, based on immunemagnetic isolation and flow cytometry. J. Immunol. Methods 247, 163-174. (Pubitemid 32057053)
16. Coltel, N., Combes, V., Wassmer, S.C., Chimini, G., and Grau, G.E. (2006). Cell vesiculation and immunopathology: implications in cerebral malaria. Microbes Infect. 8, 2305-2316. (Pubitemid 44322058)
17. Dai, S., Wei, D., Wu, Z., Zhou, X., Wei, X., Huang, H., and Li, G. (2008). Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 16, 782-790. (Pubitemid 351426181)
18. Dalton, A.J. (1975). Microvesicles and vesicles of multivesicular bodies versus "virus-like" particles. J. Natl. Cancer Inst. 54, 1137-1148.
19. Dubyak, G.R. (2012). P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol. 14, 1697-1706.
20. Ellis, T.N., Leiman, S.A., and Kuehn, M.J. (2010). Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components. Infect. Immun. 78, 3822-3831.
21. Escudier, B., Dorval, T., Chaput, N., André, F., Caby, M.-P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. (2005). Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J. Transl. Med. 3, 10.
22. Fais, S., Logozzi, M., Lugini, L., Federici, C., Azzarito, T., Zarovni, N., and Chiesi, A. (2012). Exosomes: the ideal nanovectors for biodelivery. Biol. Chem. 394, 1-15.
23. Frasch, C.E., van Alphen, L., Holst, J., Poolman, J.T., and Rosenqvist, E. (2001). Outer membrane protein vesicle vaccines for meningococcal disease. Methods Mol. Med. 66, 81-107.
24. Gatti, S., Bruno, S., Deregibus, M.C., Sordi, A., Cantaluppi, V., Tetta, C., and Camussi, G. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 26, 1474-1483.
25. Grange, C., Tapparo, M., Collino, F., Vitillo, L., Damasco, C., Deregibus, M.C., Tetta, C., Bussolati, B., and Camussi, G. (2011). Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71, 5346-5356.
26. Hata, T., Murakami, K., Nakatani, H., Yamamoto, Y., Matsuda, T., and Aoki, N. (2010). Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs. Biochem. Biophys. Res. Commun. 396, 528-533.
27. Holst, J., Martin, D., Arnold, R., Huergo, C.C., Oster, P., O'Hallahan, J., and Rosenqvist, E. (2009). Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine. 27 (Suppl) 2, B3-12.
28. Kalra, H., Simpson, R.J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V.C., Borràs, F.E., Breakefield, X., Budnik, V., et al. (2012). Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 10, e1001450.
29. Keller, S., Ridinger, J., Rupp, A.K., Janssen, J. W., and Altevogt, P. (2011). Body fluid derived exosomes as a novel template for clinical diagnostics. J. Transl. Med. 9, 86.
30. Koga, K., Matsumoto, K., Akiyoshi, T., Kubo, M., Yamanaka, N., Tasaki, A., Nakashima, H., Nakamura, M., Kuroki, S., Tanaka, M., et al. (2005). Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 25, 3703-3708.
31. Lamparski, H.G., Metha-Damani, A., Yao, J.Y., Patel, S., Hsu, D.H., Ruegg, C., and Le Pecq, J.B. (2002). Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods. 270, 211-226.
32. Langer, K., Balthasar, S., Vogel, V., Dinauer, N., von Briesen, H., and Schubert, D. (2003). Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int. J. Pharm. 257, 169-180. (Pubitemid 36507043)
33. Lima, L.G., Chammas, R., Monteiro, R.Q., Moreira, M.E., and Barcinski, M.A. (2009). Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett. 8, 168-175.
34. Luga, V., Zhang, L., Viloria-Petit, A.M., Ogunjimi, A.A., Inanlou, M.R., Chiu, E., Buchanan, M., Hosein, A.N., Basik, M., and Wrana, J.L. (2012). Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 21, 1542-1556.
35. Martin, D.R., Walker, S.J., Baker, M.G., and Lennon, D.R. (1998). New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. J. Infect. Dis. 177, 497-500. (Pubitemid 28063785)
36. Mathivanan, S. and Simpson, R.J. (2009). ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9, 4997-5000.
37. Mathivanan, S., Lim, J.W.E., Tauro, B.J., Ji, H., Moritz, R.L., and Simpson, R.J. (2009). Proteomic analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 9.2, 197-208.
38. Matzdorff, A.C., Berchner, D., Kühnel, G., Kemkes-Matthes, B., Pralle, H., and Voss, R. (1998). Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro. Haemostasis 28, 277-288. (Pubitemid 29385900)
39. McKechnie, N.M., King, B.C., Fletcher, E., and Braun, G. (2006). Fas-ligand is stored in secretory lysosomes of ocular barrier epithelia and released with microvesicles. Exp. Eye Res. 83, 304-314. (Pubitemid 43850946)
40. Meng, Y., Kang, S., and Fishman, D.A. (2005). Lysophosphatidic acid stimulates fas ligand microvesicle release from ovarian cancer cells. Cancer Immunol. Immunother. 54, 807-814. (Pubitemid 40977149)
41. Merchant, M.L., Powell, D.W., Wilkey D.W., Cummins T.D., Deegens J.K., Rood, I.M., McAfee, K.J., Fleischer, C., Klein, E., and Klein, J.B. (2010). Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics Clin. Appl. 4, 84-96.
42. Momen-Heravi, F., Balaj, L., Alian, S., Trachtenberg, A.J., Hochberg, F.H., Skog, J., and Kuo, W.P. (2012a). Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol. 3, 162.
43. Momen-Heravi, F., Balaj, L., Alian, S., Tigges, J., Toxavidis, V., Ericsson, M., Distel, R.J., Ivanov, A.R., Skog, J., and Kuo, W.P. (2012b). Alternative methods for characterization of extracellular vesicles. Front Physiol. 3, 354.
44. Morse, M.A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T.M., Valente, N., Shreeniwas, R., Sutton, M.A., Delcayre, A., et al. (2005). A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med. 3, 9.
45. Müller, G. (2012). Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab. Syndr. Obes. 5, 247-282.
46. Muralinath, M., Kuehn, M.J., Roland, K.L., and Curtiss, R. (2011). Immunization with Salmonella enterica serovar Typhimuriumderived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect. Immun. 79, 887-894.
47. Navabi, H., Croston, D., Hobot, J., Clayton, A., Zitvogel, L., Jasani, B., Bailey-Wood, R., Wilson, K., Tabi, Z., Mason, M.D., et al. (2005). Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells Mol. Dis. 35, 149-152. (Pubitemid 41267042)
48. Nieves, W., Asakrah, S., Qazi, O., Brown, K.A., Kurtz, J., Aucoin, D.P., McLachlan, J.B., Roy, C.J., and Morici, L.A. (2011). A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine. 29, 8381-8389.
49. Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García- Santos, G., Ghajar, C., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891.
50. Raposo, G., Nijman, H.W., Stoorvogel, W., Liejendekker, R., Harding, C.V., Melief, C.J., and Geuze, H.J. (1996). B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172. (Pubitemid 26113979)
51. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., and Ratajczak, M.Z. (2006). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495. (Pubitemid 44264090)
52. Scott, D.J., Harding, E., and Rowe, A.J. (2005). Analytical ultracentrifugation: techniques and methods. (Cambridge, UK: The Royal Society of Chemistry), pp. 273-276.
53. Shao, H., Min, C., Issadore, D., Liong, M., Yoon, T., Weissleder, R., and Lee, H. (2012). Magnetic nanoparticles and microNMR for diagnostic applications. Theranostics 2, 55-65.
54. Simpson, R.J. and Mathivanan, S. (2012). Extracellular microvesicles: the need for internationally recognised nomenclature and stringent purification criteria. J. Proteomics Bioinform. 5, ii-ii. doi:10.4172/jpb.10000e10.
55. Tappero, J.W., Lagos, R., Ballesteros, A.M., Plikaytis, B., Williams, D., Dykes, J., Gheesling, L.L., Carlone, G.M., Høiby, E.A., Holst, J., et al. (1999). Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. J. Am. Med. Assoc. 281, 1520-1527. (Pubitemid 29200936)
56. Tauro, B.J., Greening, D.W., Mathias, R.A., Ji, H., Mathivinan, S., Scott, A.M., and Simpson, R.J. (2012). Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56, 293-304.
57. Taylor, D.D. and Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21. (Pubitemid 351853251)
58. Taylor, D.D., Zacharias, W., and Gercel-Taylor, C. (2011). Exosome isolation for proteomic analyses and RNA profiling. Methods Mol. Biol. 728, 235-246.
59. Théry, C., Zitvogel, L., and Amigorena, S. (2002). Exosomes: Composition, Biogenesis, and Function. Nature Rev. 2, 569-578.
60. Théry, C., Amigorena, S., Raposo, G., and Clayton, A. (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3.22. DOI: 10.1002/0471143030.cb0322s30.
61. Van de Waterbeemd, B., Streefland, M., van Keulen, L., van den Ijssel, J., de Haan, A., Eppink, M.H., and van der Pol, L.A. (2012). Identification and optimization of critical process parameters for the production of NOMV vaccine against Neisseria meningitidis. Vaccine 30, 3683-3690.
62. Virgintino, D., Rizzi, M., Errede, M., Strippoli, M., Girolamo, F., Bertossi, M., and Roncali, L. (2012). Plasma membrane-derived microvesicles released from tip endothelial cells during vascular sprouting. Angiogenesis 15, 761-769.
63. Wan, S., Zhou, Z., Duan, B., and Morel, L. (2008). Direct B cell stimulation by dendritic cells in a mouse model of lupus. Arthritis Rheum. 58, 1741-1750. (Pubitemid 351847528)
64. Whitmire, W.M. and Garon, C.F. (1993). Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi. Infect. Immun. 61, 1460-1467. (Pubitemid 23099222)
65. Wiggins, R., Glatfelter, A., Kshirsagar, B., and Beals, T. (1987). Lipid microvesicles and their association with procoagulant activity in urine and glomeruli of rabbits with nephrotoxic nephritis. Lab. Invest. 56, 264-272. (Pubitemid 17065346)
66. Yamada, T., Inoshima, Y., Matsuda, T., and Ishiguro, N. (2012). Comparison of methods for isolating exosomes from bovine milk. J. Vet. Med. Sci. 74, 1523-1525.
67. Yoo, C.E., Kim, G., Kim, M., Park, D., Kang, H.J., Lee, M., Huh, N. (2012). A direct extraction method for microRNAs from exosomes captured by immunoaffinity beads. Anal. Biochem. 431, 96-98.
68. Yuana, Y., Bertina, R.M., and Osanto, S. (2011). Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb. Haemost. 105, 396-408.
69. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., and Amigorena, S. (1998). Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4, 594-600. (Pubitemid 28237359)